1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030 1.2.2 Hemophilia A Drugs 1.2.3 Hemophilia A Inhibitors Treatment 1.2.4 Von Willebrand Disease Treatment 1.3 Market by Application 1.3.1 Global Factor VIII Deficiency Treatment Market Growth by Application: 2019 VS 2023 VS 2030 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Factor VIII Deficiency Treatment Market Perspective (2019-2030) 2.2 Factor VIII Deficiency Treatment Growth Trends by Region 2.2.1 Global Factor VIII Deficiency Treatment Market Size by Region: 2019 VS 2023 VS 2030 2.2.2 Factor VIII Deficiency Treatment Historic Market Size by Region (2019-2024) 2.2.3 Factor VIII Deficiency Treatment Forecasted Market Size by Region (2025-2030) 2.3 Factor VIII Deficiency Treatment Market Dynamics 2.3.1 Factor VIII Deficiency Treatment Industry Trends 2.3.2 Factor VIII Deficiency Treatment Market Drivers 2.3.3 Factor VIII Deficiency Treatment Market Challenges 2.3.4 Factor VIII Deficiency Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Factor VIII Deficiency Treatment Players by Revenue 3.1.1 Global Top Factor VIII Deficiency Treatment Players by Revenue (2019-2024) 3.1.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Players (2019-2024) 3.2 Global Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Factor VIII Deficiency Treatment Revenue 3.4 Global Factor VIII Deficiency Treatment Market Concentration Ratio 3.4.1 Global Factor VIII Deficiency Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Factor VIII Deficiency Treatment Revenue in 2023 3.5 Factor VIII Deficiency Treatment Key Players Head office and Area Served 3.6 Key Players Factor VIII Deficiency Treatment Product Solution and Service 3.7 Date of Enter into Factor VIII Deficiency Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Factor VIII Deficiency Treatment Breakdown Data by Type 4.1 Global Factor VIII Deficiency Treatment Historic Market Size by Type (2019-2024) 4.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2025-2030) 5 Factor VIII Deficiency Treatment Breakdown Data by Application 5.1 Global Factor VIII Deficiency Treatment Historic Market Size by Application (2019-2024) 5.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2025-2030) 6 North America 6.1 North America Factor VIII Deficiency Treatment Market Size (2019-2030) 6.2 North America Factor VIII Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 6.3 North America Factor VIII Deficiency Treatment Market Size by Country (2019-2024) 6.4 North America Factor VIII Deficiency Treatment Market Size by Country (2025-2030) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Factor VIII Deficiency Treatment Market Size (2019-2030) 7.2 Europe Factor VIII Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 7.3 Europe Factor VIII Deficiency Treatment Market Size by Country (2019-2024) 7.4 Europe Factor VIII Deficiency Treatment Market Size by Country (2025-2030) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size (2019-2030) 8.2 Asia-Pacific Factor VIII Deficiency Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030 8.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2019-2024) 8.4 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2025-2030) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Factor VIII Deficiency Treatment Market Size (2019-2030) 9.2 Latin America Factor VIII Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 9.3 Latin America Factor VIII Deficiency Treatment Market Size by Country (2019-2024) 9.4 Latin America Factor VIII Deficiency Treatment Market Size by Country (2025-2030) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size (2019-2030) 10.2 Middle East & Africa Factor VIII Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 10.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2019-2024) 10.4 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2025-2030) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Detail 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Factor VIII Deficiency Treatment Introduction 11.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.1.5 Pfizer Recent Development 11.2 Takeda 11.2.1 Takeda Company Detail 11.2.2 Takeda Business Overview 11.2.3 Takeda Factor VIII Deficiency Treatment Introduction 11.2.4 Takeda Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.2.5 Takeda Recent Development 11.3 Bayer HealthCare 11.3.1 Bayer HealthCare Company Detail 11.3.2 Bayer HealthCare Business Overview 11.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Introduction 11.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.3.5 Bayer HealthCare Recent Development 11.4 CSL 11.4.1 CSL Company Detail 11.4.2 CSL Business Overview 11.4.3 CSL Factor VIII Deficiency Treatment Introduction 11.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.4.5 CSL Recent Development 11.5 Grifols 11.5.1 Grifols Company Detail 11.5.2 Grifols Business Overview 11.5.3 Grifols Factor VIII Deficiency Treatment Introduction 11.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.5.5 Grifols Recent Development 11.6 Novo Nordisk 11.6.1 Novo Nordisk Company Detail 11.6.2 Novo Nordisk Business Overview 11.6.3 Novo Nordisk Factor VIII Deficiency Treatment Introduction 11.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.6.5 Novo Nordisk Recent Development 11.7 F. Hoffmann-La Roche 11.7.1 F. Hoffmann-La Roche Company Detail 11.7.2 F. Hoffmann-La Roche Business Overview 11.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Introduction 11.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.7.5 F. Hoffmann-La Roche Recent Development 11.8 Kedrion 11.8.1 Kedrion Company Detail 11.8.2 Kedrion Business Overview 11.8.3 Kedrion Factor VIII Deficiency Treatment Introduction 11.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.8.5 Kedrion Recent Development 11.9 Octapharma 11.9.1 Octapharma Company Detail 11.9.2 Octapharma Business Overview 11.9.3 Octapharma Factor VIII Deficiency Treatment Introduction 11.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.9.5 Octapharma Recent Development 11.10 Biogen Idec 11.10.1 Biogen Idec Company Detail 11.10.2 Biogen Idec Business Overview 11.10.3 Biogen Idec Factor VIII Deficiency Treatment Introduction 11.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.10.5 Biogen Idec Recent Development 11.11 BioMarin Pharmaceutical 11.11.1 BioMarin Pharmaceutical Company Detail 11.11.2 BioMarin Pharmaceutical Business Overview 11.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Introduction 11.11.4 BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.11.5 BioMarin Pharmaceutical Recent Development 11.12 Sangamo Therapeutics 11.12.1 Sangamo Therapeutics Company Detail 11.12.2 Sangamo Therapeutics Business Overview 11.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Introduction 11.12.4 Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.12.5 Sangamo Therapeutics Recent Development 11.13 Spark Therapeutics 11.13.1 Spark Therapeutics Company Detail 11.13.2 Spark Therapeutics Business Overview 11.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Introduction 11.13.4 Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.13.5 Spark Therapeutics Recent Development 11.14 Swedish Orphan Biovitrum 11.14.1 Swedish Orphan Biovitrum Company Detail 11.14.2 Swedish Orphan Biovitrum Business Overview 11.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Introduction 11.14.4 Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.14.5 Swedish Orphan Biovitrum Recent Development 11.15 Uniqure NV 11.15.1 Uniqure NV Company Detail 11.15.2 Uniqure NV Business Overview 11.15.3 Uniqure NV Factor VIII Deficiency Treatment Introduction 11.15.4 Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.15.5 Uniqure NV Recent Development 11.16 Amarna Therapeutics 11.16.1 Amarna Therapeutics Company Detail 11.16.2 Amarna Therapeutics Business Overview 11.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Introduction 11.16.4 Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.16.5 Amarna Therapeutics Recent Development 11.17 Dimension Therapeutics 11.17.1 Dimension Therapeutics Company Detail 11.17.2 Dimension Therapeutics Business Overview 11.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Introduction 11.17.4 Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) 11.17.5 Dimension Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030 Table 2. Key Players of Hemophilia A Drugs Table 3. Key Players of Hemophilia A Inhibitors Treatment Table 4. Key Players of Von Willebrand Disease Treatment Table 5. Global Factor VIII Deficiency Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Factor VIII Deficiency Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030 Table 7. Global Factor VIII Deficiency Treatment Market Size by Region (2019-2024) & (US$ Million) Table 8. Global Factor VIII Deficiency Treatment Market Share by Region (2019-2024) Table 9. Global Factor VIII Deficiency Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 10. Global Factor VIII Deficiency Treatment Market Share by Region (2025-2030) Table 11. Factor VIII Deficiency Treatment Market Trends Table 12. Factor VIII Deficiency Treatment Market Drivers Table 13. Factor VIII Deficiency Treatment Market Challenges Table 14. Factor VIII Deficiency Treatment Market Restraints Table 15. Global Factor VIII Deficiency Treatment Revenue by Players (2019-2024) & (US$ Million) Table 16. Global Factor VIII Deficiency Treatment Market Share by Players (2019-2024) Table 17. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2023) Table 18. Ranking of Global Top Factor VIII Deficiency Treatment Companies by Revenue (US$ Million) in 2023 Table 19. Global 5 Largest Players Market Share by Factor VIII Deficiency Treatment Revenue (CR5 and HHI) & (2019-2024) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Factor VIII Deficiency Treatment Product Solution and Service Table 22. Date of Enter into Factor VIII Deficiency Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Factor VIII Deficiency Treatment Market Size by Type (2019-2024) & (US$ Million) Table 25. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2019-2024) Table 26. Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 27. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2025-2030) Table 28. Global Factor VIII Deficiency Treatment Market Size by Application (2019-2024) & (US$ Million) Table 29. Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2019-2024) Table 30. Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 31. Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2025-2030) Table 32. North America Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 33. North America Factor VIII Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million) Table 34. North America Factor VIII Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million) Table 35. Europe Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. Europe Factor VIII Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million) Table 37. Europe Factor VIII Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million) Table 38. Asia-Pacific Factor VIII Deficiency Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030 Table 39. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2019-2024) & (US$ Million) Table 40. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2025-2030) & (US$ Million) Table 41. Latin America Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 42. Latin America Factor VIII Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million) Table 43. Latin America Factor VIII Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million) Table 44. Middle East & Africa Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 45. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million) Table 46. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million) Table 47. Pfizer Company Detail Table 48. Pfizer Business Overview Table 49. Pfizer Factor VIII Deficiency Treatment Product Table 50. Pfizer Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 51. Pfizer Recent Development Table 52. Takeda Company Detail Table 53. Takeda Business Overview Table 54. Takeda Factor VIII Deficiency Treatment Product Table 55. Takeda Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 56. Takeda Recent Development Table 57. Bayer HealthCare Company Detail Table 58. Bayer HealthCare Business Overview Table 59. Bayer HealthCare Factor VIII Deficiency Treatment Product Table 60. Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 61. Bayer HealthCare Recent Development Table 62. CSL Company Detail Table 63. CSL Business Overview Table 64. CSL Factor VIII Deficiency Treatment Product Table 65. CSL Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 66. CSL Recent Development Table 67. Grifols Company Detail Table 68. Grifols Business Overview Table 69. Grifols Factor VIII Deficiency Treatment Product Table 70. Grifols Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 71. Grifols Recent Development Table 72. Novo Nordisk Company Detail Table 73. Novo Nordisk Business Overview Table 74. Novo Nordisk Factor VIII Deficiency Treatment Product Table 75. Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 76. Novo Nordisk Recent Development Table 77. F. Hoffmann-La Roche Company Detail Table 78. F. Hoffmann-La Roche Business Overview Table 79. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product Table 80. F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 81. F. Hoffmann-La Roche Recent Development Table 82. Kedrion Company Detail Table 83. Kedrion Business Overview Table 84. Kedrion Factor VIII Deficiency Treatment Product Table 85. Kedrion Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 86. Kedrion Recent Development Table 87. Octapharma Company Detail Table 88. Octapharma Business Overview Table 89. Octapharma Factor VIII Deficiency Treatment Product Table 90. Octapharma Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 91. Octapharma Recent Development Table 92. Biogen Idec Company Detail Table 93. Biogen Idec Business Overview Table 94. Biogen Idec Factor VIII Deficiency Treatment Product Table 95. Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 96. Biogen Idec Recent Development Table 97. BioMarin Pharmaceutical Company Detail Table 98. BioMarin Pharmaceutical Business Overview Table 99. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product Table 100. BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 101. BioMarin Pharmaceutical Recent Development Table 102. Sangamo Therapeutics Company Detail Table 103. Sangamo Therapeutics Business Overview Table 104. Sangamo Therapeutics Factor VIII Deficiency Treatment Product Table 105. Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 106. Sangamo Therapeutics Recent Development Table 107. Spark Therapeutics Company Detail Table 108. Spark Therapeutics Business Overview Table 109. Spark Therapeutics Factor VIII Deficiency Treatment Product Table 110. Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 111. Spark Therapeutics Recent Development Table 112. Swedish Orphan Biovitrum Company Detail Table 113. Swedish Orphan Biovitrum Business Overview Table 114. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product Table 115. Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 116. Swedish Orphan Biovitrum Recent Development Table 117. Uniqure NV Company Detail Table 118. Uniqure NV Business Overview Table 119. Uniqure NV Factor VIII Deficiency Treatment Product Table 120. Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 121. Uniqure NV Recent Development Table 122. Amarna Therapeutics Company Detail Table 123. Amarna Therapeutics Business Overview Table 124. Amarna Therapeutics Factor VIII Deficiency Treatment Product Table 125. Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 126. Amarna Therapeutics Recent Development Table 127. Dimension Therapeutics Company Detail Table 128. Dimension Therapeutics Business Overview Table 129. Dimension Therapeutics Factor VIII Deficiency Treatment Product Table 130. Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million) Table 131. Dimension Therapeutics Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global Factor VIII Deficiency Treatment Market Size Comparison by Type (2024-2030) & (US$ Million) Figure 2. Global Factor VIII Deficiency Treatment Market Share by Type: 2023 VS 2030 Figure 3. Hemophilia A Drugs Features Figure 4. Hemophilia A Inhibitors Treatment Features Figure 5. Von Willebrand Disease Treatment Features Figure 6. Global Factor VIII Deficiency Treatment Market Size Comparison by Application (2024-2030) & (US$ Million) Figure 7. Global Factor VIII Deficiency Treatment Market Share by Application: 2023 VS 2030 Figure 8. Hospitals Case Studies Figure 9. Clinics Case Studies Figure 10. Other Case Studies Figure 11. Factor VIII Deficiency Treatment Report Years Considered Figure 12. Global Factor VIII Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 13. Global Factor VIII Deficiency Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 14. Global Factor VIII Deficiency Treatment Market Share by Region: 2023 VS 2030 Figure 15. Global Factor VIII Deficiency Treatment Market Share by Players in 2023 Figure 16. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2023) Figure 17. The Top 10 and 5 Players Market Share by Factor VIII Deficiency Treatment Revenue in 2023 Figure 18. North America Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 19. North America Factor VIII Deficiency Treatment Market Share by Country (2019-2030) Figure 20. United States Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 21. Canada Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 22. Europe Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 23. Europe Factor VIII Deficiency Treatment Market Share by Country (2019-2030) Figure 24. Germany Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 25. France Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 26. U.K. Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 27. Italy Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 28. Russia Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. Nordic Countries Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. Asia-Pacific Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Asia-Pacific Factor VIII Deficiency Treatment Market Share by Region (2019-2030) Figure 32. China Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. Japan Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 34. South Korea Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 35. Southeast Asia Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 36. India Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 37. Australia Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 38. Latin America Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 39. Latin America Factor VIII Deficiency Treatment Market Share by Country (2019-2030) Figure 40. Mexico Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 41. Brazil Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 42. Middle East & Africa Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. Middle East & Africa Factor VIII Deficiency Treatment Market Share by Country (2019-2030) Figure 44. Turkey Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. Saudi Arabia Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. Pfizer Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 47. Takeda Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 48. Bayer HealthCare Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 49. CSL Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 50. Grifols Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 51. Novo Nordisk Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 52. F. Hoffmann-La Roche Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 53. Kedrion Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 54. Octapharma Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 55. Biogen Idec Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 56. BioMarin Pharmaceutical Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 57. Sangamo Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 58. Spark Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 59. Swedish Orphan Biovitrum Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 60. Uniqure NV Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 61. Amarna Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 62. Dimension Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed